Graphene Investments Sas Vertex Pharmaceuticals Inc Transaction History
Graphene Investments Sas
- $158 Billion
- Q3 2025
A detailed history of Graphene Investments Sas transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Graphene Investments Sas holds 8,300 shares of VRTX stock, worth $3.5 Million. This represents 2.06% of its overall portfolio holdings.
Number of Shares
8,300
Previous 6,800
22.06%
Holding current value
$3.5 Million
Previous $3.03 Billion
7.37%
% of portfolio
2.06%
Previous 1.97%
Shares
9 transactions
Others Institutions Holding VRTX
# of Institutions
1,797Shares Held
239MCall Options Held
1.95MPut Options Held
1.14M-
Capital World Investors Los Angeles, CA28.7MShares$12.1 Billion1.94% of portfolio
-
Vanguard Group Inc Valley Forge, PA24MShares$10.1 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$8.98 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA16.1MShares$6.78 Billion1.5% of portfolio
-
State Street Corp Boston, MA11.8MShares$4.96 Billion0.2% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $108B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...